Principal Scientist @Roche. Previously Postdoc @Cambridge_Uni, PhD @EPFL and MSc @unito. Microbiome, genomics, PRS, ML, immunology and entrepreneurship.
Basel, Switzerland
Joined October 2014
- Tweets118
- Following1.1K
- Followers249
- Likes496
Petar Scepanovic retweeted
📢Fully-funded PhD studying the comorbidities of high adiposity. 🔗: jobs.cam.ac.uk/job/48333/ (2 weeks left, due November 20)
Great work environment @CAMBRIDGE_CEU @HLRI_Cambridge, collab with @AstraZeneca @MikeXiao_JIANG @CambridgeATS.
DM or e-mail for informal enquiries.
Interested in a 4-year PhD studying the genetics of BMI and comorbidities? Don't wait, apply for my @AstraZeneca-funded studentship w/ @MikeXiao_JIANG 🔗: jobs.cam.ac.uk/job/48333/ (due October 31)!
@CAMBRIDGE_CEU @HLRI_Cambridge @Cambridgecardio @DPHPC @CambridgeATS
ALT Project description for "Partitioning the effects of high body mass index on risk of future comorbidities".
Petar Scepanovic retweeted
Out today in @NatureGenet!
Important new updates to the Polygenic Score (PGS) Catalog, & a new software tool that simplifies the calculation of polygenic scores in the context of genetic ancestry
👉 tinyurl.com/fa5ts5a3
@iamslambert @minouye271 @sritchie73 @Florent_Yvon
ALT Screen shot of the new article out in nature genetics, enhancing the polygenic score catalog with tolls for score calculation and ancestry normalization
Petar Scepanovic retweeted
Interested in a 4-year PhD studying the genetics of BMI and comorbidities? Don't wait, apply for my @AstraZeneca-funded studentship w/ @MikeXiao_JIANG 🔗: jobs.cam.ac.uk/job/48333/ (due October 31)!
@CAMBRIDGE_CEU @HLRI_Cambridge @Cambridgecardio @DPHPC @CambridgeATS
ALT Project description for "Partitioning the effects of high body mass index on risk of future comorbidities".
Petar Scepanovic retweeted
Our CEO Marcus Claesson together with @Roche and APC Microbiome just published a study showing changes in the #gutmicrobiome of non-obese mice associated with Type-1 #diabetes and anti-PD-1 #cancer #Immunotherapy journals.aai.org/immunohoriz… #microbiomeanalysis #microbiota
Petar Scepanovic retweeted
I'm delighted to release the first half of my new open-access online textbook in human population genetics:
web.stanford.edu/group/pritc…
Petar Scepanovic retweeted
Over and over again, modern behavioral genetics studies have revealed how flawed the assumption of "equal parts nature and nurture" has been. But the myth remains embedded in the conventional wisdom because numbers in the middle feel intuitively "correct".
Petar Scepanovic retweeted
One fantastic collaboration with @casanova_lab, @grvsadrian, @ShenYingZhang, and all the co-authors - just go through the thread to discover more !
1/ We are excited to share our report in @JExpMed showing that about 40% of cases of #WestNilevirus (#WNV) encephalitis are due to pre-existing auto-Abs neutralizing type I IFNs, making WNV encephalitis the best understood human infectious disease (rupress.org/jem/article/220/…).
Petar Scepanovic retweeted
Our latest research on the combined impact of genetics and infection on the risk of cardiovascular disease actu.epfl.ch/news/oral-bacte… @epflSV @CHUVLausanne
Petar Scepanovic retweeted
Pls RT! Great opportunity to attend a Summer School exclusively focused on AI & machine learning for healthcare! Offering talks, a mentorship program, student mini-projects, roundtables, networking & an online exhibition. 5-9 Sept. Learn more: tinyurl.com/2p8wue2z @minouye271
join me & @EricJCGalvez with the rest of the @Roche's pRED microbiome team in Basel to intertwine human genetics & microbiome! open postdoc position here tinyurl.com/56xmwc9z
Petar Scepanovic retweeted
Very pleased to share this exciting new work, a highly collaborative effort, on the development, validation and application of genetic scores for a wide range of multi-omic traits.
Preprint: biorxiv.org/content/10.1101/…
Online Portal: omicspred.org
Thread 1/9
This Post is from an account that no longer exists. Learn more
Petar Scepanovic retweeted
Pleased to announce our recent work is now live @CellGenomics, in which we show machine learning optimized polygenic scores for blood cell traits can stratify sex-specific trajectories and identify genetic correlations with disease.
cell.com/cell-genomics/fullt…
Thread 1/8
Petar Scepanovic retweeted
Pleased to announce our latest work is now live at Nature Metabolism (@natmetabolism), in which we show polygenic risk scores (PRS) can be used to identify novel and causal proteins underlying disease risk.
nature.com/articles/s42255-0…
Thread 1/9
Petar Scepanovic retweeted
Great read on lessons from GWAS on infectious disease phenotypes, by @jacquesfellay @cthorball and @esiborghe. sciencedirect.com/science/ar…
Petar Scepanovic retweeted
We studied microbiome dynamics in 245 FMT cases across 13 studies where fecal transplants were used to treat patients who suffered from rCDI, IBD, Metabolic Syndrome, Drug-Resistant Pathogen colonization, or went through ICI anti-tumor therapy.
xitter.gq/DanielPodlesny/status/…
Petar Scepanovic retweeted
Super excited to release genebass.org, a web application for browsing association results for 3,700 phenotypes across 281,850 individuals from the UK Biobank. The site features plots, tables, and controls for exploring billions of associations.
Petar Scepanovic retweeted
Happy to finally share this manuscript - large-scale Crohn's exomes from IIBDGC demonstrates complementarity of GWAS and exome findings and many new CD genes. Unlike neurodev - most signal from more common low-frequency variants medrxiv.org/content/10.1101/…
Petar Scepanovic retweeted
We're thrilled to release a manuscript on rare variant association testing on the exomes of 300k individuals in the UK Biobank medrxiv.org/content/10.1101/… and a browser of the results: genebass.org
Petar Scepanovic retweeted
I must admit - Robert De Niro is right: Switzerland is just too perfect, too nice. 😉🇨🇭🎥 @MySwitzerland_e #IneedSwitzerland #InLoveWithSwitzerland #paidpartnership youtube.com/watch?v=wXcBGfXX…
Petar Scepanovic retweeted
#JobAlert: My group is looking for a talented someone to help us analyze #microbiome data from our #oncology #clinicaltrials gene.com/careers/detail/2021…